[Paul Hastings] A Discussion on the Internal Investigation in the Korean Pharma Industry_6/13(화) 12PM_Paul Hastings 서울 사무소
페이지 정보
작성일17-05-25 09:41관련링크
본문
A Discussion on the Internal Investigation inthe Korean Pharma Industry
Paul Hastings invites you to join us for a complimentary roundtable discussion that will focus on how the latest regulatory enforcement on Novartis Korea has affected the Korean pharmaceutical industry, as well as providing a general view of the recent industry developments in the U.S. Korea)에 대한 관계 당국의 법 집행이 한국 제약 산업에 끼친 영향 및 미국 내 제약 산업의 최근 동향에 대해 논의할 좌담회에 귀하를 초청합니다. investigations in the pharmaceutical industry, including the recent KRW 55.1 billion (approximately US$48 million) fine on Novartis Korea for paying improper benefits to Health Care Professionals. 노바티스 코리아에게 부과된 551억원 (약 4,800만 달러)의 과징금을 포함하여 제약 산업에 대한 민형사상 조사 및 수사의 최신 동향을 다룰 것입니다. enforcement authorities, it has become advisable for pharmaceutical companies to look proactively into their operations in order to identify potential risks and implement timely remedial actions. Therefore, we will discuss parallel investigations with the U.S. Department of Justice and U.S. Securities and Exchange Commission, and recent enforcement actions against pharmaceutical companies. prosecutor. Mr. Nicholas Ahn and Mr. Han Kyu Lee, associates in the firm’s Korea Practice Group, will also join the discussion. 진행할 것입니다. 본 토론에는 저희 로펌의 한국 업무 그룹 소속인 안정수 (Nicholas Ahn) 미국변호사와 이한규(Han Kyu Lee) 미국변호사도 참여합니다. space for the seminar and will accept registrations on a first-come, first-served basis. 제한되어 있어 부득이하게 선착순으로 등록을 받고 있는 점 양해 부탁드립니다. ※ 공간상의 제약으로 법무법인 소속 변호사님께는 좌석 마련이 어려우니 양해하여 주시면 감사하겠습니다. Discussion Topics:
토론 주제:
Speakers:
Keynote Speaker 주제 발표자 Other Speakers 보조발표자 |
DATE 날짜 Tuesday, June 13, 2017 2017년 6월 13일 화요일 TIME 시간 LOCATION 장소 Language 언어 RSVP 회답 CLE Qualifications 자격요건 |
|||
| |||||||||
| |||||||||
|
Paul Hastings is a leading global law firm with a strong presence throughout Asia, Europe, Latin America, and the United States. |
|
This email was sent to ~firstName~ ~lastName~ at ~emailAddress~ You have received this email because you are on the firm's e-distribution list. If you have received this transmission in error, please notify us by reply email and delete this message and any attachments. This message is sent by a law firm and may contain information that is privileged or confidential. These materials may be considered ATTORNEY ADVERTISING in some jurisdictions. Prior results do not guarantee a similar outcome. © 2017 All Rights Reserved | Paul Hastings LLP | 515 South Flower Street, Twenty-Fifth Floor | Los Angeles, CA 90071 | www.paulhastings.com |